Number of biosimilar drugs becoming available United States 2015-2022

Published by
Matej Mikulic,
Nov 2, 2022
As of October 2022, one new biosimilar drug became available in the United States in that year, compared to seven biosimilars that became available during 2019. This statistic illustrates the number of biosimilar drugs becoming available in the United States from 2015 to 2022.

Number of biosimilars becoming available in the United States from 2015 to 2022

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

2022

Region

United States

Survey time period

2015 to 2022

Supplementary notes

* 2022 includes January to October.

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

6

Other regions

10

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in the UKGlobal pharmaceutical industryPharmaceutical industry in the U.S.AstraZenecaNational Health Service (NHS) UK
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu